ultrasound evaluation
OtherUltrasound scan of fetus in second and third trimestrers
NCT Number: NCT06628063
this study aims to help the physicians to evaluate the practice of routine Third trimestric fetal scan whether it should be routinely performed to all cases including those with low risk singleton pregnancies.
Trial opening soon.
Get Notified18 year–45 year
Female
Observational
The third-trimester ultrasound scan ,traditionally performed at 32-34weeks, can assess fetal viability , presentation, anatomy , growth, amniotic fluid volume, placental location and fetoplacental Doppler.
There are multiple other indications that can trigger a third-trimester scan, including antepartum bleeding , reduced fetal movements, preterm rupture of the membranes and suspected abnormalities of fetal growth based on physical examination. In addition, ultrasound may be used to guide other procedures in the third trimester, such as external cephalic version. However, as yet, there is no convincing evidence that routine universal third-trimester ultrasound examination in a low-risk population improves either perinatal or maternal outcome especially in low socioeconomic countries with limited resources
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ultrasound scan of fetus in second and third trimestrers
Time frame: from October 2024 to April 2025
assessing Additional benefit of 3rd Trimester scan in low risk pregnancies attending sohag university regarding detection pf fetal congenital anomalies
Contact information is provided by the study sponsor or research team.
Sohag University
Other
Second and Third Trimestric Scan Versus Second Trimestric Scan Alone in Detection of Congenital Fetal Anomalies
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07532369
Cardiovascular Abnormalities, Cardiovascular Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT01087320
Congenital Abnormalities, Congenital Anomaly
Bethesda, Maryland, United States
View Trial DetailsNCT05071859
Congenital Abnormalities, Congenital Anomaly
Houston, Texas, United States
View Trial DetailsNCT04856436
Benzodiazepines Causing Adverse Effects in Therapeutic Use, Congenital Abnormalities
Suwon, Gyeonggi-do, South Korea
View Trial Details